Psychedelics as Catalysts for Change, Cody J.Wenthur, 12/01 @wednesdaynitethelab8948
Psychedelics as Catalysts for Change, Cody J.Wenthur, 12/01  @wednesdaynitethelab8948
Uploaded December 2021 | Updated November 2026, 3 days ago
Psychedelic-assisted psychotherapy approaches using ketamine, MDMA, or psilocybin have shown substantial promise in human trials for the treatment of difficult psychiatric conditions including end-of-life anxiety, treatment resistant depression, and post-traumatic stress disorder. However, there remain many important questions regarding the mechanisms by which these interventions lead to both rapid and lasting behavioral change. Using translational approaches that range from organic synthesis to human studies, the Wenthur Lab is interrogating the role of acute corticosteroid release in the behavioral outcomes following psilocybin administration, assessing polypharmacologic contributions of active metabolites to ketamine’s functional profile, and investigating how differential self-identity and experiential memory contribute to variation in clinical psychedelic studies. In this talk, Dr. Wenthur will discuss the results of these studies to date, highlighting the possible means by which psychedelics may act as molecular change agents, and he will also share insights into how the design and development of these psychedelic research studies have acted to change the trajectory of his own career development thus far.
Bio: Cody Wenthur is an innovative, translational investigator in psychopharmacology who has been on the UW–Madison faculty since 2018. His work is focused on improving our understanding of the basis for beneficial and detrimental effects of opioids, cannabinoids, psychedelics, and other neuroplasticity-inducing approaches in the context of novel therapeutic approaches for promoting and maintaining mental health. His research program has received both basic and clinical grant and fellowship support from NIGMS, NIDA, NIMH, independent foundations, and philanthropic funds. The resulting findings have been published in leading journals such as Nature and PNAS and have yielded the development of first-in-class tool compounds and generated new pharmacologic techniques for the investigation of complex psychoactive mixtures. His scientific research is complemented by his dedicated support of graduate education in neuropharmacology, including active service as the founding director of the Psychedelic Pharmaceutical Investigation Master’s program, and mentorship of PharmD and PhD students in the Pharmaceutical Sciences, Molecular and Cellular Pharmacology, and Neuroscience Training Programs.
Psychedelics as Catalysts for Change, Cody J.Wenthur, 12/01Vaccines in Dogs & Comparative Immunotherapy Trials, David Vail, 3/3/21Unpacking the SARS-CoV-2 Virus, Designing Vaccines Against the Covid-19 DiseaseRobert KirchdoerferObserving the Extremes of Antarctic Weather and ClimateWinged Sentinels: How Birds are Coping with Climate Change Benjamin Zuckerberg, 10/6/21Life in the Late Triassic in Wyoming: A Timely Story of Puzzle Pieces Dave Lovelace, 5/26/21Dunes, Dust, Drought, and Downpours: Evolution of Great Plains LandscapesPositive Youth Development at the Intersection of Arts and Public Health Taylor Seale, 11/3/21Ticks and tickborne disease in Wisconsin and the upper Midwest, Susan Paskewitz, Plato, 3/31/21Algae Blooms in Wisconsin Lakes: Are They Really Getting Worse? Grace Wilkinson, 10/20/21Physical Therapy Management of Osteoarthritis in the Hip and Knee Jill Then-Nissenbaum, 03/23/2022The WiBee app: The Wisconsin Wild Bee community-science project to count and learn about bees!
Wednesday Nite @ The Lab |

"Psychedelics as Catalysts for Change", Cody J.Wenthur, 12/01

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER